As of 2025-05-17, the EV/EBITDA ratio of Panacos Pharmaceuticals Inc (PANC) is 0.09. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PANC's latest enterprise value is -3.16 mil USD. PANC's TTM EBITDA according to its financial statements is -33.85 mil USD. Dividing these 2 quantities gives us the above PANC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-02-04 | 0.09 |